 .png)
.png)
Report Library
View More
Datamonitor Healthcare Oncology Dis...
April 8, 2021
Datamonitor Healthcare Infectious D...
April 7, 2021
Datamonitor Healthcare CNS Disease ...
March 31, 2021
Datamonitor Healthcare CV&Met Disea...
March 31, 2021
Datamonitor Healthcare CV&Met Disea...
March 31, 2021
Datamonitor Healthcare Oncology Dis...
March 31, 2021
Datamonitor Healthcare CNS Disease ...
March 29, 2021
Datamonitor Healthcare Oncology Dis...
March 26, 2021
Datamonitor Healthcare Oncology Dis...
March 25, 2021
Datamonitor Healthcare Oncology Dis...
March 25, 2021
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 4/8/21 | Eli Lilly (LLY) | Olumiant for COVID-19 Treatment | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/8/21 | Merck (MRK) | Keytruda for Renal Cell Cancer (RCC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/6/21 | AstraZeneca (AZN) | Roxadustat for Anemia Due to Chronic Renal Failure, Dialysis-Independent | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/6/21 | Valneva (VLA) | VLA2001 for COVID-19 Prevention | Subscribers Only | Subscribers Only | Subscribers Only |
| 4/5/21 | ACADIA Pharmaceuticals (ACAD) | Nuplazid for Dementia | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 10/01/21 - 12/31/20 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 04/10/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 04/10/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 04/10/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
